SCHOTT Pharma AG & Co KgaA
XETRA:1SXP

Watchlist Manager
SCHOTT Pharma AG & Co KgaA Logo
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Watchlist
Price: 28.24 EUR 2.1%
Market Cap: 4.3B EUR
Have any thoughts about
SCHOTT Pharma AG & Co KgaA?
Write Note

SCHOTT Pharma AG & Co KgaA
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SCHOTT Pharma AG & Co KgaA
Revenue Peer Comparison

Comparables:
E
EVT
GXI

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Revenue
€898.6m
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
Evotec SE
XETRA:EVT
Revenue
€788.4m
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
24%
Gerresheimer AG
XETRA:GXI
Revenue
€2B
CAGR 3-Years
12%
CAGR 5-Years
7%
CAGR 10-Years
5%

See Also

What is SCHOTT Pharma AG & Co KgaA's Revenue?
Revenue
898.6m EUR

Based on the financial report for Sep 30, 2023, SCHOTT Pharma AG & Co KgaA's Revenue amounts to 898.6m EUR.

What is SCHOTT Pharma AG & Co KgaA's Revenue growth rate?
Revenue CAGR 3Y
15%

Over the last year, the Revenue growth was 9%. The average annual Revenue growth rates for SCHOTT Pharma AG & Co KgaA have been 15% over the past three years .

Back to Top